Revelation Biosciences, Inc. (NASDAQ:REVB) | Finanzwire

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Headlines Articles Press releases Revelation Biosciences, Inc.

Home
Companies
Revelation Biosciences, Inc.

BRIEF

published on 12/01/2025 at 15:05, 3 days 21 hours ago

Revelation Biosciences Secures Quorum for Upcoming Special Meeting

Special Meeting Future Development FDA Submission Revelation Biosciences Gemini Formulation
PRESS RELEASE

published on 12/01/2025 at 15:00, 3 days 21 hours ago

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
Revelation Biosciences, Inc. achieves quorum for Special Meeting on December 3, 2025, announces FDA meeting update & financial results. The company focuses on rebalancing inflammation using Gemini

Financial Results Special Meeting Inflammation FDA Meeting Revelation Biosciences
BRIEF

published on 11/20/2025 at 15:05, 14 days 21 hours ago

Revelation Biosciences Advances Toward FDA Meeting on Acute Kidney Injury Treatment

Clinical Trial Acute Kidney Injury FDA Meeting Gemini Revelation Biosciences
PRESS RELEASE

published on 11/20/2025 at 15:00, 14 days 21 hours ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
Revelation Biosciences announces FDA submission for Gemini as AKI treatment with positive PRIME study results. Company focuses on rebalancing inflammation

Inflammation FDA Submission Gemini Revelation Biosciences AKI Treatment
BRIEF

published on 11/06/2025 at 22:20, 28 days 14 hours ago

Revelation Biosciences Reports Improved Financial Results

Financial Results Clinical Study Revelation Biosciences Gemini Formulation Inflammatory Conditions
PRESS RELEASE

published on 11/06/2025 at 22:15, 28 days 14 hours ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025
Revelation Biosciences, Inc. reports financial results for Q3 2025 and highlights milestone achievements in clinical study and fundraising, focusing on rebalancing inflammation for health optimization

Financial Results Clinical Study Inflammation Revelation Biosciences Health Optimization
BRIEF

published on 10/29/2025 at 14:05, 1 month 6 days ago

Revelation Biosciences Reschedules Special Meeting Due to Technical Issues

Shareholders Special Meeting Reschedule Revelation Biosciences Technical Issue
PRESS RELEASE

published on 10/29/2025 at 14:00, 1 month 6 days ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
Revelation Biosciences cancels Special Meeting of Stockholders due to technical difficulty, sets new date. Focus on rebalancing inflammation with Gemini formulation

Special Meeting Stockholders Inflammation Revelation Biosciences Gemini Formulation
BRIEF

published on 10/15/2025 at 23:05, 1 month 20 days ago

Revelation Biosciences Adjourns Special Meeting to October 29, 2025

Special Meeting Virtual Meeting Proxy Materials Revelation Biosciences Stockholders Vote
PRESS RELEASE

published on 10/15/2025 at 23:00, 1 month 20 days ago

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
Revelation Biosciences adjourns 2025 Special Meeting of Stockholders due to insufficient shares. New meeting date set for October 29, 2025. Encourages stockholders to vote

Special Meeting Stockholders Voting Revelation Biosciences Adjourned

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 11 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 16 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 46 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 41 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 46 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 40 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 46 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 46 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 31 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 16 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 1 minute ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 46 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 1 minute ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 2 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE